Globus Medical (NYSE: GMED) reported Q1 EPS of $0.29, $0.01 better than the analyst estimate of $0.28. Revenue for the quarter came in at $139.3 million versus the consensus estimate of $140.3 million.

Globus Medical reaffirmed FY2016 guidance.

For earnings history and earnings-related data on Globus Medical (GMED) click here.